Novartis
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Beyond's analysis on Novartis
- — Novartis reports positive trial results for a new multiple sclerosis therapy with reduced liver toxicity
- — Henlius and Sandoz partner to co‑develop up to ten biosimilar mAb and ADC assets, aiming to accelerate global market access and revenue generation
- — Novartis delivered Q2 2026 sales growth and advanced its drug pipeline while reaffirming its full-year financial guidance
- — Novartis reports Q2 sales growth, pipeline advances, and reaffirms full‑year 2026 guidance
Recent news mentioning Novartis
- — Pharmabranche: Rückschlag bei Herzmedikament – Novartis-Aktie im Minus
- — Novartis, Ionis Tumble On Surprise Flop For Heart Drug
- — Novartis (NVS)’s Latest Basel Move Signals a Shift in Strategic Priorities
- — Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products
- — Medizin: Novartis verkündet Studienerfolg von MS-Mittel
- — Pharmaindustrie: Novartis stoppt nach Todesfällen Studien zu Zelltherapie
- — Why Novartis, Lilly, and Bristol Myers Are Eyeing This Clinical-Stage Cancer Play